economics
ASIA, BEIJING, BRAZIL, CANADA, CENTERS FOR DISEASE CONTROL, CHINA, DONALD TRUMP, DOUG FORD, ECONOMICS, ENFORCEMENT ADMINISTRATION, EUROPE, FOR DISEASE CONTROL, GEOPOLITICS, MEXICO, MINISTRY OF COMMERCE, NATIONAL SECURITY, NORTH AMERICA, ONTARIO, SOUTH AMERICA, TARIFFS, TRUMP, UKRAINE, UNITED STATES, US, US DRUG ENFORCEMENT ADMINISTRATION, US-CHINA RELATIONS, WASHINGTON, WORLD TRADE ORGANIZATION
Isaac Bennett
0 Comments
China Warns of Countermeasures After Trump’s New Tariff Announcement
China has pledged to implement “countermeasures” in response to President Trump’s announcement of a new 10% tariff on Chinese goods, attributed to fentanyl smuggling. The Chinese government accused the U.S. of deflecting blame regarding the opioid crisis and called for dialogue to address disputes. The situation reflects the ongoing tensions in U.S.-China trade relations.
Following United States President Donald Trump’s recent announcement of a new 10% tariff on Chinese imports, China has responded by warning of potential “countermeasures.” This tariff is part of Trump’s ongoing strategy to combat the importation of fentanyl, a synthetic opioid, which he attributes to high overdose rates in the United States.
In summary, China’s Ministry of Commerce criticized the U.S. tariffs, emphasizing the country’s strict drug laws and accusing Washington of avoiding responsibility for the opioid crisis. The Ministry called for constructive dialogue to resolve trade disputes and reiterated that unilateral tariffs violate international trade agreements. The ongoing tensions highlight the complexities of U.S.-China relations regarding trade and the opioid epidemic.
Original Source: www.aljazeera.com
Post Comment